In the frigid weeks of the US Congressional winter recess, the halls of government buildings around Capitol Hill are empty and quiet. But things are far from quiet for Frankie Trull, a biotechnology lobbyist. With the changing of the Congressional guard following the 2008 election comes a changing of the staff members that liaise with Trull's Washington, DC-based boutique firm, Policy Directions. This means a whole new set of people she has to convince of the merits of biotech.












